UBS has a buy on Indian Hotels with the target price at Rs 900. Analysts said the company reported resilient Jan-March quarter (Q4FY26) numbers despite geopolitical headwinds, with consolidated revenues rising 14% on the year (YoY) to Rs 2,770 crore and profit after tax (PAT) up 15% YoY to Rs 600 crore.This was underpinned by strong operating metrics with core hotel revenue per available room (RevPAR) growing 10% YoY (12% YoY on a standalone basis) driven by average room rate (ARR) growth, while occupancies improved 100 basis points (100 basis points, or bps = 1 percentage point) to 78%.The management flagged a Rs 40–45 crore impact from West Asia-related disruptions in March. Analysts said during Q4FY26 the hospitality major’s earnings before interest, taxes, depreciation, and amortisation (EBITDA) margins remained healthy at 35%, supported by cost discipline and sharp 30% YoY growth in management fees to Rs 220 crore.Looking ahead, the company’s management guided a 12–14% revenue growth in FY27, driven by resilient domestic demand, and limited supply additions.Kotak Institutional Equities has a reduce rating on UPL with the target price at Rs 650. Analysts said UPL reported an 18% YoY revenue growth for Q4FY26, with a 10 percentage point boost from foreign exchange, although a Rs 350 crore voluntary provision and a higher tax rate constrained earnings growth.Amid an uncertain outlook, management has restricted guidance to just Q1FY27, analysts said. The company’s reorganization plan remains very much on the agenda. An $87 million investment in Sinova to reduce its debt, at elevated valuations, is a concern for analysts.HSBC has a buy rating on Oberoi Realty with the target price raised to Rs 2,100. Analysts said that the company’s core strength was all in the core market of Goregaon in Mumbai, with both residential demand and office occupancy picking up.They expect an acceleration of new launches and sustained momentum for high quality residential products. The downside risks are slowdown in luxury real estate market and a delay in launches.CLSA has an outperform rating on PVR with the target price at Rs 2,135. Analysts said the company’s Q4FY26 revenue of Rs 155 crore was up 24% YoY and in line with estimates. Its movie ticket sales rose 27% YoY, EBITDA was at Rs 450 crore, up 60% YoY, and reported PAT was Rs 190 crore.FY26 admissions were at 15 crore, up 10% YoY, along with its highest ever revenue, EBITDA, average ticket price (ATP) and food & beverages spends per head (F&B SPH). PVR Inox is funding expansion via internal accruals and its FY26 free cash flow more than doubled to Rs 790 crore.Citigroup has a buy on Nuvama with the target price at Rs 2,050. Analysts said Nuvama witnessed strong momentum across segments, with sustained traction in net new flows in the wealth segments; a sharp recovery in asset servicing revenues; and stable to improving profit before tax (PBT) margin in all segments ex-AMC in FY2026.The company’s PAT was up 6% on the quarter (QoQ). Nuvama’s focus on expanding its business scope and gradual realization of leverage benefits is likely to further aid profitability over the medium-term underpinning constructive stance.(Disclaimer: Recommendations and views on the stock market, other asset classes or personal finance management tips given by experts are their own. These opinions do not represent the views of The Times of India)